Slide 1: Regulation 30 intimation of investor presentation
Date: May 12, 2025 Ref. No.: KDL/SE/015/2024‐25 To, To, BSE Limited National Stock Exchange of India Limited Corporate Relationship Department Exchange Plaza, Plot No. C‐1, Block G, 25th Floor, Phiroze Jeejeebhoy Towers Bandra Kurla Complex, Bandra (East) Dalal Street, Mumbai‐ 400001 Mumbai – 400051
Slide 2: FY2025 Result Presentation
FY2025 Result Presentation One of INDIA’S LARGEST Differentiated Diagnostic Service Provider May 2025
Slide 3: Krsnaa Diagnostics Limited
_@ Krsnaa Diagnostics Limited
Slide 4: About the Company
ABOUT THE Financial COMPANY Performance 180 Krsnaa Diagnostics is one of the fastest growing and differentiated CT/ MRI Centres diagnostic service provider with services including radiology, pathology and tele-radiology 117 Pathology Labs Provides quality and inclusive diagnostic services at disrupt
Slide 5: Krsnaa Diagnostics Financial Performance at a Glance FY25
FY25Diagnostics Krsnaa Financial Performance Financial- At a Glance INR in mn except EPS, NABL & NABH Particulars FY25 FY24 Growth Particulars FY25 FY24 Growth Revenue 7,172 6,196 16% EPS 23.6 17.3 36% No. of Patient EBIDTA 1,958 1,466 34% 19.2 15.6 23% Served No. of Test EBIDTA Margin 27% 24% 370 b
Slide 6: Growth Prospects
Growth Krsnaa Prospects Diagnostics Financial- At a Glance Radiology Pathology CT Centre Laboratory 158 180 Retail 143 150 117 118 No. of Touch Points 10,000 FY25 FY27E FY27P FY25 FY27E FY27P 4,000 1,673 MRI Centre Collection Centres 608 875 75 362 5,000 60 3,478 3,741 Q1FY25 Q2FY25 Q3FY25 Q4FY25 FY
Slide 7: Growth Strategy
Growth Krsnaa StrategyFinancial- At a Glance Diagnostics Bidding & Winning Tenders Profitability Tap the growing and underpenetrated Driving profitability through cost diagnostic market by participating in leadership new PPP tender Integrated Diagnostics Awareness Continue to enhance our Integrated
Slide 8: Competitive Advantages
—@® Competitive Advantages
Slide 9: Driving Excellence Through Quality
Driving Krsnaa Excellence Diagnostics Through Financial- At Quality a Glance India’s 1st CAP Accredited India’s 1st NABH Accredited Lab at Government Facility Tele-Radiology Hub 51 31 National Accreditation for Board of National Accreditation Board for testing's & Calibration Laboratories Hospitals
Slide 10: Our Pricing - Everyone Can Afford
Our Pricing- Krsnaa “Everyone Diagnostics Can Financial- At Afford” a Glance % lower from Segment Test Competition 1 Competition 2 Competition 3 Krsnaa competitors Radiology CT Brain 4,500 4,500 3,500 880 (75)% Radiology MRI Brain 8,000 8,250 7,000 1,340 (81)% Pathology CBC 250 250 200 37 (82)% Path
Slide 11: PAN India Presence
PAN India Krsnaa Presence Diagnostics Financial- At a Glance Well Diversified Regional Revenue Mix 14% 31% FY2025 36% 19% West South North East India map for representation only and not to scale 9
Slide 12: Industry Opportunity
—@® Industry Opportunity
Slide 13: Indian Diagnostics Industry
Indian Krsnaa diagnostics Diagnostics industry Financial- At a Glance Diagnostics service under-penetrated Share of diagnostics in healthcare Diagnostic test per year per capita 21 19 19 70% 17 12 11 10 35% 9 20% 2 6% 1 Share of Share of Share of % Decisions based Diagnostics Sector Diagnostics Cost
Slide 14: Opportunity in PPP
Opportunity Krsnaa in PPP Diagnostics Financial- At a Glance 01 02 03 The FDSI scheme aims to establish 2,000 radiology centers, with the objective of The Government emphasized the For pathology services, only 12 out of installing one CT scanner in every district necessity of public-private partners
Slide 15: Opportunity in Retail
Opportunity Krsnaa in Retail Diagnostics Financial- At a Glance Growth Potential NCD Surge Preventive Testing • India’s diagnostics market is • The growing prevalence of • Preventive diagnostics have projected to grow from $13 non-communicable diseases experienced a strong CAGR of billion to $25 bil
Slide 16: Krsnaa Retail - RPL
—@® Krsnaa Retail - RPL
Slide 17: Krsnaa Retail - RPL
Krsnaa Krsnaa Retail - RPL Diagnostics Financial- At a Glance • Focuse on increasing our presence in 4 • Leveraging existing infrastructure for states i.e. Maharashtra, Assam, Odisha Radiology & Pathology both for better and Punjab patient care • Current exclusie network of 250 • Capitalizing on cur
Slide 18: Krsnaa in Retail Business
Growth Krsnaa in Retail Financial- Diagnostics BusinessAt a Glance Retail Network Key Geographies Total Touch Points (Count) 798 1,673 267 246 875 Maharashtra 608 Punjab 362 Assam Odisha Powered by Bing © GeoNames, Microsoft, TomTom Q1 Q2 Q3 Q4 “Within a year, touch points increased by 4X acros
Slide 19: Krsnaa Foray into Retail: In-Shop Branding
ForayDiagnostics Krsnaa into RetailFinancial- At a Glance IN-SHOP BRANDING 17
Slide 20: Preventive Healthcare - Wellness Packages for All
ForayDiagnostics Krsnaa into RetailFinancial- At a Glance PREVENTIVE HEALTHCARE - WELLNESS PACKAGES FOR ALL 18
Slide 21: Health Checkup Camp/Awareness
ForayDiagnostics Krsnaa into RetailFinancial- At a Glance HEALTH CHECKUP CAMP/AWARENESS 19
Slide 22: KBA-FOFO/FOCO Centre
ForayDiagnostics Krsnaa into RetailFinancial- At a Glance KBA-FOFO/FOCO CENTRE 20
Slide 23: RPL - Branding & Awareness Initiatives
RPL - Branding Financial & Awareness Initiatives Performance Krsnaa Retail Premier League in an Continuous Medical Education (CME) Association with Conference- Indian Medical Association (IMA) Advancement in Image Diagnostics MediFest Conference in an Association with Indian Medical Association (IMA
Slide 24: Awards & Accolades
Awards Krsnaa & Accolades Diagnostics Financial- At a Glance Best Diagnostic Lab Leading HR Chain of the year Transformation (West) Award 22
Slide 25: Financial Performance
—@® Financial Performance
Slide 26: Krsnaa - At a Glance FY25
FY25Diagnostics Krsnaa - At a Glance Financial- At a Glance In mn Revenue from operation EBIDTA PAT FY25 7,172 FY25 1,958 FY25 776 FY24 6,196 1 6 % FY24 1,466 3 4 % FY24 568 3 7 % EBIDTA Margin PAT Margin Earning Per Share FY25 27% FY25 11% FY25 23.6 370 FY24 24% bps FY24 9% 165 bps FY24 17.3
Slide 27: Krsnaa - At a Glance Q4FY25
Q4FY25 Krsnaa – At a Glance Diagnostics Financial- At a Glance In mn Revenue from operation EBIDTA PAT Q4FY25 1,861 Q4FY25 542 Q4FY25 207 Q4FY24 1,663 12% Q4FY24 446 21% Q4FY24 187 11% EBIDTA Margin PAT Margin Earning Per Share Q4FY25 29% Q4FY25 11% Q4FY25 6.3 230 1 bps Q4FY24 27% bps Q4FY24
Slide 28: Centre Maturity Profile
Centre Krsnaa Maturity Profile Diagnostics Financial- At a Glance Krsnaa Younger Portfolio Continues to Mature with Promising Future 26% 2% 33% 42% 24% 35% Net ROCE Net Net ROCE ROCE Block Block Block Notes: 1. Net Block % is calculated as on the year ended 31st March 2025 2. Maturity is on the basi
Slide 29: Consolidated Financial Performance
Consolidated Krsnaa Financial Diagnostics Performance Financial- At a Glance In mn Particulars Q4 FY 25 Q3 FY 25 Q4 FY 24 FY 25 FY 24 Amount % Amount % Amount % Amount % Amount % Revenue from operations 1,861 1,745 1,663 7,172 6,196 Expenses Cost of Material Consumed 415 22% 399 23% 430 26% 1,693 24
Slide 30: Consolidated Balance Sheet
Consolidated Krsnaa Financial Diagnostics Performance Financial- At a Glance (INR In Mn) Assets Mar 31, 2025 Mar 31, 2024 Liabilities Mar 31, 2025 Mar 31, 2024 Non-current assets Equity Equity share capital 161.45 161.45 Property, plant and equipment 6,674.34 6,447.21 Other equity 8,666.25 7,936.57
Slide 31: Contact Information
Contact Contact Information Information This presentation contains statements that are “forward looking statements” including, but without limitation, statements relating to the implementation of strategic initiatives, and other statements relating to Krsnaa Diagnostics’ future business developments